MARCOL Health is a division of MARCOL. A specialist investor providing capital, commercial and strategic guidance for healthcare services and technology businesses.
MARCOL Health is committed to improving the quality of and access to care, for millions of people across Europe, whilst helping to reduce the costs associated with healthcare delivery. The businesses sit at the convergence of healthcare delivery and technology.
At MARCOL Health, we apply our expertise and resources to turn proven business models into scalable platforms that accelerate growth and drive international expansion.
CEO - MARCOL Health
Ed joined MARCOL in 2015 with more than 25 years’ experience within the health sector across the UK and Europe, the US and North America, Latin America and Asia Pacific.
Ed has built and managed several international healthcare businesses that included private-equity-backed operations in developed and emerging markets, as well as acquiring and integrating established companies across international regions. The health operations included care delivery, health technology & management, mental health, diagnostics and wellness. Prior to this he worked for the world’s largest healthcare business based out of the US, UnitedHealth Group, where he led their international health services & technology operations ‘Optum’.
At MARCOL Health, Ed brings with him extensive experience in scaling healthcare businesses and helping develop go-to-market strategies across the majority of the healthcare spectrum.
Particular interest in proven businesses that are technology enabled or data-led, where both these capabilities help ensure the expansion of new innovations that can be achieved at scale and are able to be internationalised.
Group Chief Financial Officer
Brian Cole joined MARCOL in 2015. Previously he was CFO International Operations at London & Regional Properties. He has over 20 years of experience in real estate investment and corporate finance, including complex cross border transactions, M&A and capital raising. He has held senior finance roles in real estate, private healthcare and retail companies with investments and operations both in the UK and internationally.
Brian heads and controls the Group’s finance function to help MARCOL’s continued growth in real estate, healthcare and venture-capital operations in the UK, Europe and elsewhere.
Mark joined MARCOL Health at the beginning of 2019 as Investment Director supporting the ongoing growth and development of the MARCOL Health Portfolio. Mark’s responsibilities include sourcing, evaluating and executing new investments in high growth companies in the Healthtech sector, as well as providing ongoing support in strategic development, M&A structuring, and monitoring of existing portfolio companies.
Prior to joining MARCOL, Mark worked for a private equity firm focusing on pan-European deals within the technology and healthcare sectors, having formerly worked at PWC as Senior Associate in their Strategy team.
Mark holds a BBS Honors Degree in Business Studies from Trinity College Dublin.
Romain Weber joined MARCOL in November 2019 as Investment Director. Romain supports the investment team in the sourcing and execution of new private equity opportunities. He also advises the existing portfolio companies on strategic corporate finance matters and business development.
Prior to joining MARCOL, Romain worked for a private investment fund involved in public and private markets. Before that, he was an Associate Director in the investment banking division of HSBC where he held various M&A and Corporate Finance advisory roles in London and Dubai.
Romain holds a Masters in Finance from London Business School and is a graduate from Sciences Po Strasbourg in France.
James joined MARCOL Health in November 2020 as Investment Manager supporting the growth and development of the MARCOL Health Portfolio. James’ responsibilities include sourcing, evaluating and executing new investments in the Healthcare sector, and providing support in strategic development, M&A, and monitoring of portfolio companies.
Before joining MARCOL, James was CEO and majority shareholder of a Healthcare Management Consultancy focusing on Primary Care. Prior to this he worked in Private Equity focusing on the UK mid-market, and began his career at PwC.
James holds a BSc Honours Degree in International Securities, Investment and Banking from the University of Reading, an MSc in Finance from Imperial College London, and is a qualified accountant with the ICAEW.
Matthes joined MARCOL’s investment team in February 2021 as Investment Manager and is responsible for sourcing, evaluating and executing new investments. He also supports the monitoring and strategic development of existing portfolio companies.
Before joining MARCOL, Matthes worked at Citigroup in their Industrials M&A group in London and then moved into a growth investing and portfolio management role at Virgin Management Limited, Richard Branson’s family office. Matthes also spent three years at the Avington Group where he performed advisory and investment work in the hospitality, real estate and consumer industries.
Matthes holds an MSc in Finance from Bocconi University and Bachelor Degrees in Economics and Business Administration and Japanese Studies from Goethe University Frankfurt.
Senior Strategy Associate
Saarung Shah joined MARCOL in December 2021 as Senior Strategy Associate. He is responsible for undertaking market research and mapping, commercial due diligence on new investments and acquisitions, and working with portfolio companies on strategic projects post-acquisition.
Prior to joining MARCOL, Saarung worked as an investment professional focused on venture and growth capital investment at BGF and Ingenious, and as a strategy consultant focused on commercial due diligence and corporate strategy.
Saarung holds a BSc Economics degree from the University of Nottingham.
MARCOL Health recognised many years ago that healthcare globally needed to develop and adapt to the growing demands of the healthcare systems, as well as becoming more aligned with greater consumer/patient expectations and awareness.
We therefore focused on business models that were working towards the ideal combination of improving quality of and access to care through efficient means, with technology and international potential at the heart. These have included telehealth services, online pharmacies, diagnostic imaging centres/technology and innovative enterprise platforms, some of which today are recognised as European leaders in their fields achieving tremendous growth and valuations.
MARCOL Health is constantly searching for companies that have strong and visionary teams with proven models within large existing sectors of healthcare, ripe for disruption and with the ability to scale and expand internationally. Working in partnership with existing founders and shareholders, MARCOL looks for ways in which our support can maximise value in the most effective way, leveraging its significant internal expertise and resources.